Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: A review

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 3, 1997, Pages 353-361

  Yamamoto, Shinji ^a   Wanibuchi, Hideki ^a   Hori, Taka Aki ^a   Yano, Yoshihisa ^a   Matsui Yuasa, Isao ^a,b   Otani, Shuzo ^a   Chen, Hua ^a   Yoshida, Kaoru ^a   Kuroda, Koichi ^a   Endo, Ginji ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Dimethylarsinic acid; Liver caricinogenesis; Ornithine decarboxylase; Promoting activity; Urinary bladder carcinogenesis

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; CACODYLIC ACID; CARCINOGEN; METHYLNITROSOUREA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; ORNITHINE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLADDER CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; IN VIVO STUDY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA; MAMMALIA;

EID: 0030838412     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00017-3     Document Type: Review

References (42)

1. Baroni, C., van Esch, G.J., Saffiotti, U., 1963. Carcinogenesis tests of two inorganic arsenicals. Arch. Environ. Health 7, 668-674.
2. Bates, M.N., Smith, A.H., Hopenhayn-Rich, C., 1992. Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 135, 462-476.
3. Bishop, J.M., 1987. The molecular genetics of cancer. Science 235, 305-311.
4. Boutwell, R.K., 1963. A carcinogenicity evaluation of potassium arsenite and arsanilic acid. J. Agric. Food Chem. 11, 381-384.
5. Brown, C.C., Chu, K.C., 1983. Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J. Natl. Cancer Inst. 70, 455-463.
6. Brown, J.L., Kitchin, K.T., 1996. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis. Cancer Lett. 98, 227-231.
7. Buchet, J.P., Lauwerys, R., Roels, H., 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
8. Chen, C.J., Wang, C.J., 1990. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 50, 5470-5474.
9. Cohen, S.M., Ellwein, L.B., 1990. Cell proliferation in carcinogenesis. Science 249, 1007-1011.
10. Crecelius, E.A., 1977. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19, 147-150.
11. Cuzick, J., Evans, S., Gillman, M., Price, E.D., 1982. Medicinal arsenic and internal malignancies. Br. J. Cancer 45, 904-911.
12. Endo, G., Kuroda, K., Okamoto, A., Horiguchi, S., 1992. Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull. Environ. Contam. Toxicol. 48, 131-137.
13. Fearon, E.R., Vogelstein, B., 1990. A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
14. Fukushima, S. (1991) Modification of tumor development in the urinary bladder, in: N. Ito and H. Sugano (Eds.) Modification of Tumor Development in Rodents, Prog. Exp. Tumor Res., Vol. 33, pp. 154-174.
15. Fukushima, S., Hagiwara, A., Hirose, M., Yamaguchi, S., Tiwawech, D., Ito, N., 1991. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats. Jpn. J. Cancer Res. 82, 642-649.
16. Fukushima, S., Tanaka, H., Asakawa, E., Kagawa, M., Yamamoto, A., Shirai, T., 1992. Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale. Cancer Res. 52, 1675-1680.
17. Greenblatt, M.S., Bennett, W.P., Hollstein, M., Harris, C.C., 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
18. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C., 1991. p53 mutations in human cancers. Science 253, 49-53.
19. Hsieh, L.L., Chen, H.J., Hsieh, J.T., Jee, S.H., Chen, G.S., Chen, C.J., 1994. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations. Cancer Lett. 86, 59-65.
20. IARC (1980) Arsenic and arsenic compounds, in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 23, IARC, Lyon, pp. 39-141.
21. Ito, N., Tatematsu, M., Nakanishi, K., Hasegawa, R., Takano, T., Imaida, K., Ogiso, T., 1980. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gann 71, 832-842.
22. Ito, N., Tsuda, H., Tatematsu, M., Inoue, T., Tagawa, Y., Aoki, T., Uwagawa, S., Kagawa, M., Ogiso, T., Masui, T., Imaida, K., Fukushima, S., Asamoto, M., 1988. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 9, 387-394.
23. Ito, N., Hasegawa, R., Sano, M., Tamano, S., Esumi, H., Takayama, S., Sugimura, T., 1991. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP). Carcinogenesis 12, 1503-1506.
24. Lee, T.C., Tanaka, N., Lamb, P.W., Gilmer, T.M., Barrett, J.C., 1988. Induction of gene amplification by arsenic. Science 241, 79-81.
25. Leonard, A., 1984. Recent advances in arsenic mutagenesis and carcinogenesis, Toxicol. Environ. Chem. 7, 241-250.
26. Li, J.-H., Rossman, T.G., 1989. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2, 1-9.
27. Loeb, L.A., 1994. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 54, 5059-5063.
28. Masui, T., Don, I., Takada, N., Ogawa, K., Shirai, T., Fukushima, S., 1994. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 15, 2379-2381.
29. Matsui, I., Wiegand, L., Pegg, A.E., 1981. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J. Biol. Chem. 256, 2454-2459.
30. Okui, T., Fujiwara, Y., 1986. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutation Res. 172, 69-76.
31. Petres, J., Baron, D., Hagedorn, M., 1977. Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ. Health Perspect. 19, 223-227.
32. Rossman, T.G., Stone, D., Molina, M., Troll, W., 1980. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ. Mutagen. 2, 371-379.
33. Shibata, A., Ohneseit, P.F., Tsai, Y.C., Spruck III, C.H., Nichols, P.W., Chiang, H.S., Lai, M.K., Jones, P.A., 1994. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15, 1085-1087.
34. Shirai, T., Fukushima, S., Tagawa, Y., Okumura, M., Ito, N., 1989. Cell proliferation induced by uracil-calculi and subsequent development of reversible papillomatosis in the rat urinary bladder. Cancer Res. 49, 378-383.
35. Takada, N., Matsuda, T., Otoshi, T., Yano, Y., Otani, S., Hasegawa, T., Nakae, D., Konishi, Y., Fukushima, S., 1994. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res. 54, 2895-2899.
36. Tseng, W.P., 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19, 109-119.
37. 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ. Res. 21, 446-457.
38. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13, 259-264.
39. H. Wanibuchi, S. Yamamoto, H. Chen, K. Yoshida, G. Endo, T. Hori, S. Fukushima. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats, Carcinogenesis (17) (1997) 2435-2439.
40. Yamamoto, S., Masui, T., Murai, T., Mori, S., Oohara, T., Makino, S., Fukushima, S., Tatematsu, M., 1995a. Frequent mutations of the p53 gene and infrequent H-and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 16, 2363-2368.
41. Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M.-A., Matsui-Yuasa, I., Otani, S., Kuroda, K., Endo, G., Fukushima, S., 1995b. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55, 1271-1276.
42. Yamanaka, K., Hayashi, H., Kato, K., Hasegawa, A., Okada, S., 1995. Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells. Biochem. Biophys. Res. Commun. 207, 244-249.